Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
PaperCitations, authors & open-access status
Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 68 citations, 2019 year and bronze oa status.
68
Citations
2019
Year
bronze
OA Status